Subscribe
type here...
Subscribe
HomeNews

News

Manufacturing

Russia wants to take down barriers for global production, distribution of vaccines

Techno -
Russia actively fosters localization of its vaccine production abroad, which is based on technology transfer, while agreements were inked with several foreign companies.
Manufacturing

Single-dose Sputnik Light vaccine registered in Kazakhstan

Techno -
Sputnik Light demonstrated 79.4% efficacy according to analyzed data taken from 28 days after the injection was administered. In February 2021, Kazakhstan approved the two-dose Sputnik V vaccine.
Regulatory

WTO issues joint indicative list of critical inputs for COVID-19 vaccines

Techno -
The WTO Secretariat has published an indicative list compiling information on the critical inputs for the manufacturing, distributing and administering of COVID-19 vaccines.
Manufacturing

RDIF and Serum Institute of India to start production of Sputnik vaccine in September

Techno -
The first batch of Sputnik vaccine is expected to be produced at SII’s facilities in September. The parties intend to produce over 300 million doses of the vaccine in India per year.
Manufacturing

R-Pharm and Frontier Biotech will provide Russia with a new drug for the treatment of HIV

Techno -
Aikening™ is a new fusion inhibitor. It is the first and only long-acting injectable (as IV infusion QW) available as a dual therapy for treatment-experienced patients with HIV-1 replication.
Drug Development

Sputnik V vaccine effective against new variants of coronavirus

Techno -
Sputnik V pioneered the vaccine cocktail approach with two shots. The tests conducted by the Gamaleya Center have demonstrated validity of this approach.
1...979899...117Page 98 of 117
spot_img

Expert Articles

spot_img

PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).

Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.

Company

Headlines

Newsletter

Get important news delivered directly to your inbox and stay connected!

© PHARMPROM 2026